- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Corbus Pharmaceuticals Holding (CRBP)
18.3200
-0.2000(-1.08%)
Closed
After Hours
18.3800+0.0600(+0.3275%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
18.1100
18.7200
52 wk Range
3.0334
61.9000
CRBP Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Corbus Pharmaceuticals Holding stock price live, this page displays NASDAQ CRBP stock exchange data. View the CRBP premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Corbus Pharmaceuticals Holding real time stock price chart below.
What Is the Corbus Pharmaceuticals Holding Stock Price Today?
The Corbus Pharmaceuticals Holding stock price today is 18.3200.
What Is the Stock Symbol for Corbus Pharmaceuticals Holding?
The stock ticker symbol for Corbus Pharmaceuticals Holding is CRBP.
Is CRBP the Same as $CRBP?
$CRBP is a common way to refer to the Corbus Pharmaceuticals Holding ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Corbus Pharmaceuticals Holding Trade On?
Corbus Pharmaceuticals Holding is listed and trades on the NASDAQ stock exchange.
Is Corbus Pharmaceuticals Holding a Good Stock to Buy?
Determining whether Corbus Pharmaceuticals Holding—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Corbus Pharmaceuticals Holding share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CRBP quote. (ISIN: US21833P3010)
What Is the Corbus Pharmaceuticals Holding Stock Price Today?
The Corbus Pharmaceuticals Holding stock price today is 18.3200.
What Is the Stock Symbol for Corbus Pharmaceuticals Holding?
The stock ticker symbol for Corbus Pharmaceuticals Holding is CRBP.
Is CRBP the Same as $CRBP?
$CRBP is a common way to refer to the Corbus Pharmaceuticals Holding ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Corbus Pharmaceuticals Holding Trade On?
Corbus Pharmaceuticals Holding is listed and trades on the NASDAQ stock exchange.
Is Corbus Pharmaceuticals Holding a Good Stock to Buy?
Determining whether Corbus Pharmaceuticals Holding—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Corbus Pharmaceuticals Holding share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CRBP quote. (ISIN: US21833P3010)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
18.110018.7200
52 wk Range
3.033461.9000
UnlockCRBP Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
63.0000
Upside
+243.8865%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
3 analysts have revised their earnings upwards for the upcoming period
InvestingPro Research for Corbus Pharmaceuticals Holding
Catalysts Ahead | Upcoming ASCO presentation and Novo Nordisk's trial results could significantly impact Corbus's stock, potentially driving a 40% increase with positive outcomes |
Analyst Optimism | Wall Street sets bullish price targets, with RBC Capital Markets at $82 and Wedbush Securities at $85, reflecting confidence in Corbus's growth potential |
Financial Fortitude | With a market cap of $609M and cash reserves of $120.1M, Corbus is well-positioned to fund operations and advance clinical programs for at least 12 months |
Pipeline Promise | Corbus Pharmaceuticals' focus on novel cancer and obesity therapeutics showcases potential in rapidly expanding markets, with key assets CRB-701 and CRB-913 leading the charge |
Corbus Pharmaceuticals Holding Company Profile
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, develops products to defeat serious illness. It develops CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E (MMAE), which is in Phase I clinical trial; CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells for the treatment of solid tumors; CRB-913, a peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, including the Jenrin library of approximately 600 compounds, and multiple issued and pending patent filings. The company was incorporated in 2009 and is based in Norwood, Massachusetts.
Compare CRBP to Peers and Sector
Metrics to compare | CRBP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCRBPPeersSector | |
|---|---|---|---|---|
P/E Ratio | −6.3x | −2.6x | −0.6x | |
PEG Ratio | −0.12 | 0.09 | 0.00 | |
Price / Book | 1.8x | 1.5x | 2.6x | |
Price / LTM Sales | - | 30.4x | 3.2x | |
Upside (Analyst Target) | 259.1% | 211.5% | 48.5% | |
Fair Value Upside | Unlock | 11.3% | 7.8% | Unlock |
People Also Watch
FAQ
What Is the Corbus Pharmaceuticals Holding (CRBP) Stock Price Today?
The Corbus Pharmaceuticals Holding stock price today is 18.32
What Stock Exchange Does Corbus Pharmaceuticals Holding Trade On?
Corbus Pharmaceuticals Holding is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for Corbus Pharmaceuticals Holding?
The stock symbol for Corbus Pharmaceuticals Holding is "CRBP."
What Is the Corbus Pharmaceuticals Holding Market Cap?
As of today, Corbus Pharmaceuticals Holding market cap is 220.64M.
What is Corbus Pharmaceuticals Holding Earnings Per Share?
The Corbus Pharmaceuticals Holding EPS is -4.96.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.